PEGylation, the process of attaching polyethylene glycol (PEG) molecules to another compound, notably proteins or peptides, has gained considerable attention in the fields of biochemistry and ...
San Carlos, Calif., April 9, 2007 -- Innovative pulmonary and PEGylation-based therapeutic product development is the focus of two new business units recently created at Nektar Therapeutics (Nasdaq: ...
PEGylation has been around for 30 years and it is surprising that it is still widely used given the significant advances that have been made in biopharmaceutical manufacture since then. So why is this ...
Acquisition will add PolyPEG and GlycoPol technologies to existing PEGylation platforms. U.K. firm PolyTherics has acquired Warwick Effect Polymers (WEP), which provides specialty biopolymers based on ...
A recent study by researchers from Institute of Science Tokyo unveils the molecular mechanisms explaining why some "stealth" ...
Pro Bono Bio Group (PBB) exercised an option to take out an exclusive, global license to PolyTherics’ TheraPEG™ platform for use in the development and commercialization of a TheraPEG-FVIII product ...
BRIDGEWATER, N.J.--(BUSINESS WIRE)-- Enzon Pharmaceuticals, Inc. (Nasdaq: ENZN) today announced new data will be presented on Locked Nucleic Acid (LNA) based antisense oligonucleotide programs ...
SAN CARLOS, Calif., May 16 -- Nektar Therapeutics (Nasdaq: NKTR) announced initial results today from a Phase 1 study of NKTR- 102, PEGylated irinotecan. The data shows significant anti-tumor activity ...
In exemplifying the site specific PEGylation technology with single domain antibodies and interferons, Almac has demonstrated that therapeutically important complex biological proteins can be ...
Itraconazole (ITZ) is an antifungal agent used clinically to treat mycotic infections. However, its therapeutic effects are limited by low solubility in aqueous media. Liposome-based delivery systems ...